We recently published a list of Why These 10 Firms Soared on Monday. In this article, we are going to take a look at where ...

With starvation and the collapse of healthcare systems now prevalent across the Gaza Strip, there are mounting calls for ...

Market watchers see Grab’s street-hail operator licence as a way to secure a reliable supply of drivers, giving ComfortDelGro ...

According to a head-to-head trial called DEVOTE, which underpins the applications, the high-dose slowed neurodegeneration faster at day 64 than ... a green light in 2019. Biogen made $1.15 billion ...

is pleased to announce the signing of a commercial-scale Supply Agreement for copper-64 with Nusano. Nusano's 190,000 square foot state-of-the-art facility in West Valley City, Utah is expected ...

They don’t have a lot of competition, they’re largely domestic, they don’t need a strong economy, you can’t tariff them out of existence, they have scale, and most have fat margins ...

India's first dengue vaccine, expected to launch in 2026 after local trials; WHO-approved jab offers two-dose protection ...

Palantir Technologies Inc. (NASDAQ:PLTR) is a software company specializing in data integration and analytics platforms for large-scale decision ... revenue growing 64% YoY and US government ...

The pill form is in line with injectable GLP-1 drugs, like Novo Nordisk's Ozempic, a diabetes drug also used for weight loss. The positive data gives the company the green light to file the drug ...